A new hope for precision medicine

Sci Transl Med. 2013 Oct 23;5(208):208fs38. doi: 10.1126/scitranslmed.3007622.

Abstract

The SS1P immunotoxin is combined with immunomodulatory therapy in order to improve its efficacy in human mesothelioma (Hassan et al., this issue).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • GPI-Linked Proteins / immunology*
  • Humans
  • Immunosuppression Therapy*
  • Male
  • Mesothelin
  • Mesothelioma / immunology*
  • Mesothelioma / therapy*
  • Peritoneal Neoplasms / immunology*
  • Peritoneal Neoplasms / therapy*

Substances

  • Antibodies, Monoclonal
  • GPI-Linked Proteins
  • SS1(dsFv)PE38
  • Mesothelin